Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
986
datasets available to search
ShareScore release 0.9.0
Dataset results
986 results for “classic”
A Study of Tislelizumab as Monotherapy in Relapsed or Refractory Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT03209973. IPD Sharing: YES. Countries: 1. Publications: 3.
Efficacy and Safety Evaluation of IBI308 in Treatment of Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma
ClinicalTrials.gov study NCT03114683. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Nevanimibe HCl for the Treatment of Classic CAH
ClinicalTrials.gov study NCT03669549. IPD Sharing: NO. Countries: 5. Publications: 1.
A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)
ClinicalTrials.gov study NCT00317642. IPD Sharing: Not stated. Countries: 5. Publications: 1.
PD-1 Antibody SHR-1210 in Patients With Relapsed or Refractory Classic Hodgkin's Lymphoma
ClinicalTrials.gov study NCT03155425. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Participants With Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study)
ClinicalTrials.gov study NCT04806451. IPD Sharing: NO. Countries: 10. Publications: 1.
Doxorubicin Hydrochloride, Pembrolizumab, Vinblastine, and Dacarbazine in Treating Patients With Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT03331341. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase II Study of Oral Panobinostat in Adult Participants With Relapsed/Refractory Classical Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00742027. IPD Sharing: Not stated. Countries: 13. Publications: 2.
Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment
ClinicalTrials.gov study NCT00574249. IPD Sharing: Not stated. Countries: 15. Publications: 1.
Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT01118026. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT00540007. IPD Sharing: NO. Countries: 1. Publications: 2.
Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational)
ClinicalTrials.gov study NCT02181738. IPD Sharing: Not stated. Countries: 10. Publications: 6.
Nivolumab & Brentuximab Vedotin Consolidation After Autologous SCT in Patients With High-Risk Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT03057795. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT00369681. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS (CLASSIC-MS)
ClinicalTrials.gov study NCT03961204. IPD Sharing: YES. Countries: 29. Publications: 1.
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
ClinicalTrials.gov study NCT03907488. IPD Sharing: YES. Countries: 3. Publications: 2.
A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II)
ClinicalTrials.gov study NCT00373529. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Avelumab In Patients With Previously Treated Advanced Stage Classical Hodgkin's Lymphoma (JAVELIN HODGKINS)
ClinicalTrials.gov study NCT02603419. IPD Sharing: NO. Countries: 3. Publications: 1.
Ibrutinib in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT02824029. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT03226249. IPD Sharing: Not stated. Countries: 1. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.